53 related articles for article (PubMed ID: 25591590)
1. Clinical significance of microRNA-24 expression in esophageal squamous cell carcinoma.
Dong W; Li B; Wang Z; Zhang Z; Wang J
Neoplasma; 2015; 62(2):250-8. PubMed ID: 25591590
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and predictive significance of serum microRNA-7 in esophageal squamous cell carcinoma.
Dong W; Li B; Wang J; Song Y; Zhang Z; Fu C; Zhang P
Oncol Rep; 2016 Mar; 35(3):1449-56. PubMed ID: 26708917
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zheng S; Zhang X; Wang X; Li J
Cancer Biomark; 2017 Jul; 20(1):49-54. PubMed ID: 28759955
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of 4 types of microRNA in serum as biomarkers of esophageal squamous cell carcinoma.
Wang K; Chen D; Meng Y; Xu J; Zhang Q
Oncol Lett; 2018 Jul; 16(1):1196-1204. PubMed ID: 29963194
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma.
Wang C; Li Q; Liu F; Chen X; Nesa EU; Guan S; Liu B; Han L; Tan B; Wang D; Chen P; Liu X; Zhang H; Sun Y; Cheng Y
Biomarkers; 2016 Sep; 21(6):517-22. PubMed ID: 27152453
[TBL] [Abstract][Full Text] [Related]
7. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
Zhang T; Wang Q; Zhao D; Cui Y; Cao B; Guo L; Lu SH
Clin Sci (Lond); 2011 Nov; 121(10):437-47. PubMed ID: 21658006
[TBL] [Abstract][Full Text] [Related]
8. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
Xue L; Nan J; Dong L; Zhang C; Li H; Na R; He H; Wang Y
Cancer Biomark; 2017; 19(2):193-197. PubMed ID: 28211800
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma.
Kurashige J; Kamohara H; Watanabe M; Tanaka Y; Kinoshita K; Saito S; Hiyoshi Y; Iwatsuki M; Baba Y; Baba H
J Surg Oncol; 2012 Aug; 106(2):188-92. PubMed ID: 22354855
[TBL] [Abstract][Full Text] [Related]
10. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy.
Yu H; Duan B; Jiang L; Lin M; Sheng H; Huang J; Gao H
Am J Transl Res; 2013; 6(1):71-7. PubMed ID: 24349623
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.
Komatsu S; Ichikawa D; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Imamura T; Kiuchi J; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Am J Cancer Res; 2016; 6(7):1511-23. PubMed ID: 27508093
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients.
Chan CM; Lai KKY; Ng EKO; Kiang MN; Kwok TWH; Wang HK; Chan KW; Law TT; Tong DK; Chan KT; Lee NP; Law S
Oncol Lett; 2018 Mar; 15(3):3273-3280. PubMed ID: 29435069
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma.
Mori Y; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Ogawa R; Katada T; Harata K; Tanaka T; Shiozaki M; Fujii Y
Mol Med Rep; 2009; 2(2):235-9. PubMed ID: 21475818
[TBL] [Abstract][Full Text] [Related]
15. CYFRA21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma.
Yi Y; Li B; Wang Z; Sun H; Gong H; Zhang Z
Biomarkers; 2009 Nov; 14(7):480-5. PubMed ID: 19863186
[TBL] [Abstract][Full Text] [Related]
16. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma.
Yan HJ; Wang RB; Zhu KL; Jiang SM; Zhao W; Xu XQ; Feng R
Chin Med J (Engl); 2012 Apr; 125(8):1410-5. PubMed ID: 22613644
[TBL] [Abstract][Full Text] [Related]
19. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
[TBL] [Abstract][Full Text] [Related]
20. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
